Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
- GC64938 AZD-7648 An inhibitor of DNA-PK
- GC64936 TD52 dihydrochloride A derivative of erlotinib
-
GC20020
3,4-Dihydroxyflavone
3',4'-二羟基黄酮
A synthetic flavonoid with diverse biological activities - GC64864 EJMC-1 EJMC-1 是一种中度有效的 TNF-α 抑制剂,IC50 为 42 μM。
-
GC64862
Tricetin
三粒小麦黄酮
Tricetin 是一种有效的竞争性 Keap1-Nrf2 蛋白相互作用 (PPI) 抑制剂。Tricetin 作用于帕金森病模型,通过激活 Nrf2/HO-1 信号通路和阻止线粒体依赖性细胞凋亡 (apoptosis) 通路来保护 6-OHDA 诱导的神经毒性。 - GC64855 PD-1/PD-L1-IN-23 PD-1/PD-L1-IN-23 是一种有效的、具有口服活性的 PD-1/PD-L1 抑制剂。PD-1/PD-L1-IN-23 是 L7 的酯类前药。L7 是一种苯并[c][1,2,5]恶二唑衍生物,在生物学上被评估为 PD-L1 的抑制剂。PD-1/PD-L1-IN-23 在同基因和 PD-L1 人源化小鼠的肿瘤模型中显示出显着的抗肿瘤作用。
-
GC64839
Varlilumab
伐立鲁单抗,CDX-1127
Varlilumab (CDX-1127) 是一种首创的人 IgG1 抗 CD27 单克隆抗体。Varlilumab 具有抗肿瘤活性。 -
GC64786
Hellebrigenin
蟾蜍它里定
Hellebrigenin,属于心脏活性类固醇的丁二烯内酯之一,从中药中分离出来。Hellebrigenin 诱导 DNA 损伤和细胞周期 G2/M 阻滞。 Hellebrigenin 触发线粒体介导的细胞凋亡。 - GC64768 PK9327 PK9327 是一种小分子稳定剂,靶向空腔的 p53 癌症突变。
- GC64767 ISIS 104838 ISIS 104838是一种反义寡核苷酸药物,可减少肿瘤坏死因子 (TNF-alpha) 的产生。TNF-alpha 可以导致类风湿关节炎关节疼痛和肿胀。
-
GC64762
3,6-Dihydroxyflavone
3,6-二羟基黄酮,3,6-DHF
3,6-Dihydroxyflavone 是一种抗癌剂。3,6-Dihydroxyflavone 剂量和时间依赖性地降低细胞活力并通过激活半胱天冬酶级联、切割聚 (ADP-核糖) 聚合酶 (PARP) 诱导 apoptosis。3,6-Dihydroxyflavone 增加细胞内氧化应激和脂质过氧化。 - GC64726 10-Formyl-5,8-dideazafolic acid 10-Formyl-5,8-dideazafolic acid 是一种胸苷酸合成酶 (thymidylate synthase) 抑制剂。
- GC64674 ABBV-167 ABBV-167 是一种 BCL-2 抑制剂 venetoclax 的磷酸盐前药。
-
GC64662
Helichrysetin
蜡菊亭; 4,2',4'-三羟基-6'-甲氧基查耳酮
Helichrysetin,分离于 Helichrysum odoratissimum 的花朵中, 是一种ID2 (DNA 结合抑制剂 2) 抑制剂,可抑制DCIS (原位导管癌) 的形成。Helichrysetin 对细胞生长具有很强的抑制作用,并且能够诱导 A549 细胞凋亡 (apoptosis)。 - GC64649 Cjoc42 Cjoc42 是一种能够与gankyrin 结合的化合物。Cjoc42 以剂量依赖性方式抑制 gankyrin 活性。Cjoc42 可防止通常与大量 gankyrin 相关的 p53 蛋白水平降低。Cjoc42 恢复 p53 依赖性转录和对 DNA 损伤的敏感性。
- GC64645 Sappanchalcone Sappanchalcone 从 Caesalpinia sappan L. 中提取的黄酮类化合物,诱导人结肠癌细胞凋亡 (apoptosis)。
-
GC64619
β-Ionone
β-紫罗兰酮
β-Ionone 可有效诱导胃腺癌细胞 SGC7901 凋亡 (apoptosis)。具有抗肿瘤活性。 -
GC64561
Toripalimab
特瑞普利单抗
Toripalimab 是首个国产抗肿瘤 PD-1 抗体。Toripalimab 是一种靶向 PD-1 的选择性人源化单克隆抗体。Toripalimab 能够与 PD-1 结合并阻断与其配体相互作用。Toripalimab 具有强效抗肿瘤作用,可用于黑色素瘤、肺癌、消化道肿瘤、肝胆和胰腺肿瘤、神经内分泌肿瘤、鼻咽癌和尿路上皮癌等肿瘤的研究。
- GC64485 HXR9 hydrochloride HXR9 hydrochloride 是一种细胞渗透性肽,是 HOX/PBX 相互作用 (HOX/PBX interaction) 的竞争性拮抗剂。HXR9 hydrochloride 拮抗 HOX 与第二转录因子 (PBX) 之间的相互作用,PBX 与旁系同源基因组 1 至 8 中的 HOX 蛋白结合。HXR9 hydrochloride 选择性地减少细胞增殖并促进 HOXA/PBX3 基因高水平表达的细胞,例如 MLL 重排的白血病细胞中的细胞凋亡 (apoptosis)。
-
GC64467
Lisaftoclax
APG-2575; Bcl-2/Bcl-xl inhibitor 1
APG-2575 (lisaftoclax) is a dual Bcl-2 and Bcl-xl inhibitor with IC50 values of 2 nM and 5.9 nM for Bcl-2 and Bcl-xl, respectively. - GC52115 S-99 An inhibitor of ASK1
-
GC52104
Ponatinib (hydrochloride)
泊那替尼盐酸盐,AP24534 hydrochloride
An inhibitor of native and mutant Bcr-Abl - GC52101 Brazilein A phytochemical with diverse biological activities
-
GC52076
Temozolomide Acid
3,4-二氢-3-甲基-4-氧代咪唑并[5,1-D]-1,2,3,5-四嗪-8-甲酰胺酸
An active metabolite of temozolomide - GC52057 QN523 An anticancer agent
-
GC52049
Myricetin 3-galactoside
杨梅素 3-O-半乳糖苷
A flavonoid with diverse biological activities -
GC19959
Methylprednisolone acetate
泼尼松龙EP杂质
A synthetic glucocorticoid and an ester form of methylprednisolone -
GC19936
Quisinostat dihydrochloride
QUISINOSTAT二盐酸盐,JNJ-26481585 dihydrochloride
A pan-HDAC inhibitor -
GC49913
Davunetide (acetate)
AL-108, NAP, NAPVSIPQ
A neuroprotective ADNP-derived peptide -
GC49883
DAPK Substrate Peptide (trifluoroacetate salt)
Death-associated Protein Kinase Substrate Peptide
A DAPK1 peptide substrate -
GC49872
10-Formyltetrahydrofolate (sodium salt) (technical grade)
10-CHO-FH4, 10-CHO-THF, N10-Formyltetrahydrofolate, 10-formyl H4PteGlu, 10-fTHF
A formyl donor and cofactor -
GC49860
Pyropheophorbide a methyl ester
焦脱镁叶绿酸Α甲酯,Pyropheophorbide-a methyl ester
A photosensitizer -
GC49855
Harmalol (hydrochloride hydrate)
骆驼蓬酚盐酸盐(二水)
A β-carboline alkaloid and an active metabolite of harmaline -
GC49849
3-Aminosalicylic Acid
3-氨基水杨酸
A salicylic acid derivative -
GC49842
Digoxigenin Bisdigitoxoside
Bisdigoxigenin
A Na+/K+-ATPase inhibitor -
GC49781
Benomyl
苯菌灵
A carbamate pesticide -
GC49773
Albendazole sulfone-d3
阿苯哒唑砜-D3
An internal standard for the quantification of albendazole sulfone -
GC49760
SN-38 Glucuronide
SN-38葡糖苷酸,SN-38G
A phase II metabolite of irinotecan - GC49753 LCS3 An inhibitor of glutathione reductase and thioredoxin reductase
- GC64375 Difopein TFA Difopein (TFA) 是 14-3-3 protein (一种高度保守的真核调节分子) 的特异性竞争性抑制剂,可阻止 14-3-3 与靶蛋白结合的能力,并抑制 14-3-3/配体的相互作用。Difopein (TFA) 诱导细胞凋亡 (apoptosis) 并增强顺铂杀死细胞的能力。
-
GC64373
Tezacitabine
替扎西他滨
Tezacitabine 是一种具有细胞生长抑制和细胞毒性的抗代谢药,是一种核苷类似物。Tezacitabine 不可逆地抑制核糖核苷酸还原酶 (ribonucleotide reductase) 并干扰 DNA 复制和修复。Tezacitabine 有效诱导细胞凋亡 (apoptotic),可用于白血病和实体瘤的研究。 - GC64370 Kongensin A Kongensin A 是一种从 Croton kongensis 中分离的天然产物。 Kongensin A 是一种有效的,共价的 HSP90 抑制剂,可阻断 RIP3 依赖性坏死病。Kongensin A 是一种有效的坏死性抑制剂和凋亡诱导剂,并具有潜在的抗坏死性和消炎性应用。
-
GC64354
Bendamustine
宾达氮芥,SDX-105 free base
Bendamustine (SDX105) is a nitrogen mustard drug used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. -
GC64352
L-Glutamic acid-15N
L-谷氨酸 15N
L-Glutamic acid-15N 是一种 15N 标记的 L-Glutamic acid。L-Glutamic acid 作为一种兴奋性氨基酸神经递质,为谷氨酸盐受体所有亚型(代谢型红藻氨酸、NMDA 和 AMPA)的激动剂。对 DA 从多巴胺能神经末梢释放的过程有激动作用。 -
GC64331
Ritonavir-13C,d3
ABT 538-13C,d3; RTV-13C,d3
Ritonavir-13C,d3 (ABT 538-13C,d3) 是一种 13C- 和氘代标记的 Ritonavir。Ritonavir (ABT 538) 是用于研究 HIV 感染和 AIDS 的 HIV 蛋白酶的抑制剂。Ritonavir 也是 SARS-CoV 3CLpro 的抑制剂,IC50 为 1.61 μM。 -
GC64325
Ligustilide
蒿本内酯
Ligustilide is the most abundant bioactive ingredient in Rhizoma Chuanxiong, a Chinese medicinal herb commonly used for the treatment of cardiovascular ailments. Solutions are best fresh-prepared. - GC64303 S2116 S2116 是 N-烷基化的反式环丙胺 (TCP) 衍生物,是一种有效的赖氨酸特异性脱甲基酶 1 (LSD1) 抑制剂。S2116 在超级增强子区域增加 H3K9 甲基化和相应的 H3K27 脱乙酰化。S2116 抑制 NOTCH3 和 TAL1 基因的转录,从而诱导 TCP 抵抗性急性淋巴细胞白血病 T-ALL 细胞凋亡 (apoptosis)。S2116 显着延迟异种移植小鼠中 T-ALL 细胞的生长。
-
GC64223
Sophocarpine monohydrate
槐果碱水合物
An alkaloid with diverse biological activities -
GC64139
Dibromoacetic acid
二溴乙酸
Dibromoacetic acid 是一种卤乙酸,常作为消毒副产品存在于饮用水中的,可引起许多不良反应,包括免疫毒性和诱导凋亡 (apoptosis) 等。 -
GC64127
Xylopine
木番荔枝碱
Xylopine 是一种阿朴啡生物碱,对癌细胞具有细胞毒活性。Xylopine 诱导氧化应激,导致癌细胞的 G2/M 细胞周期停滞和细胞凋亡 (apoptosis)。